These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8277690)

  • 41. [Immunologic aspects of chronic inflammatory intestinal diseases].
    Auer IO
    Klin Padiatr; 1983; 195(5):337-41. PubMed ID: 6632712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
    Stange EF; Schmid M; Fellermann K; Wehkamp J
    Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
    Duchmann R; Lochs H; Kruis W
    MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
    Schüssler P; Kruis W; Marget W
    Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The immunologic basis of inflammatory bowel disease.
    Strober W; James SP
    J Clin Immunol; 1986 Nov; 6(6):415-32. PubMed ID: 2878011
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical importance of organ-specific antibodies in ulcerative colitis and Crohn disease].
    Goischke EM; Zilly W
    Z Gastroenterol; 1992 May; 30(5):319-24. PubMed ID: 1378673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
    Lyanga J; Davis P; Thomson AB
    West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recent trends in the etiological studies of idiopathic inflammatory bowel diseases].
    Tsuchiya M; Morishita T; Morizane T
    Nihon Rinsho; 1977 May; 35(5):1812-20. PubMed ID: 196127
    [No Abstract]   [Full Text] [Related]  

  • 51. Autoimmune factors in inflammatory bowel disease.
    Solomon GE
    Mt Sinai J Med; 1976; 43(5):602-24. PubMed ID: 792686
    [No Abstract]   [Full Text] [Related]  

  • 52. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
    Marcussen H; Bendixen G
    Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
    [No Abstract]   [Full Text] [Related]  

  • 53. [Are Crohn disease and ulcerative colitis the results of an immunoregulatory disturbance?].
    Raedler A; Schmiegel WH; Thiele HG
    Immun Infekt; 1982 Sep; 10(5):175-9. PubMed ID: 6757110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the pathogenesis of Crohn's disease similar to that juvenile recurrent pyelonephritis? A study of lipid A antibody titers in Crohn's disease, ulcerative colitis and acute enteritis.
    Marget W; Schüssler P; Kruis W; Weinzierl M; Rindfleisch G
    Infection; 1976; 4(2):110-2. PubMed ID: 947846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease.
    MacDermott RP
    Med Clin North Am; 1994 Nov; 78(6):1207-31. PubMed ID: 7967905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immunology of chronic ulcerative colitis and Crohn's disease.
    Shorter RG; Tomasi TB; Huizenga KA; Spencer RJ; Stobo JD
    Ann N Y Acad Sci; 1976; 278():586-91. PubMed ID: 786126
    [No Abstract]   [Full Text] [Related]  

  • 57. The pathogenesis of ulcerative and granulomatous colitis. Surgical implications.
    Brooke BN
    Surg Clin North Am; 1972 Aug; 52(4):971-8. PubMed ID: 5047534
    [No Abstract]   [Full Text] [Related]  

  • 58. Local complement activation in inflammatory bowel disease.
    Halstensen TS; Brandtzaeg P
    Immunol Res; 1991; 10(3-4):485-92. PubMed ID: 1955776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atopy in inflammatory bowel disease.
    Mee AS; Brown D; Jewell DP
    Scand J Gastroenterol; 1979; 14(6):743-6. PubMed ID: 531506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered patterns of secretion of IgA and IgG subclasses by ulcerative colitis and Crohn's disease intestinal mononuclear cells.
    MacDermott RP; Nash GS; Scott MG; Nahm MH; Bertovich MJ; Kodner IJ
    Adv Exp Med Biol; 1987; 216A():335-44. PubMed ID: 3687528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.